Literature DB >> 29406937

State of the Heart: An Overview of the Disease Burden of Cardiovascular Disease from an Epidemiologic Perspective.

Robert P Lennon1, Keith A Claussen2, Karl A Kuersteiner3.   

Abstract

Cardiovascular diseases are prevalent worldwide and have significant impact on morbidity, mortality, and overall health care costs. Common risk factors include obesity, hypertension, hyperlipidemia, diabetes mellitus, chronic kidney disease, and smoking. Both modifiable and nonmodifiable risks should be accounted for when evaluating and managing patients with cardiovascular diseases. The complex nature of cardiovascular disease is not fully understood. Therefore, primary care physicians must balance what is known, what is suspected, and each patient's individual preferences to create an optimal treatment plan. Published by Elsevier Inc.

Entities:  

Keywords:  Cardiovascular disease; Chronic kidney disease; Diabetes mellitus; Hyperlipidemia; Hypertension; Obesity

Mesh:

Year:  2018        PMID: 29406937     DOI: 10.1016/j.pop.2017.11.001

Source DB:  PubMed          Journal:  Prim Care        ISSN: 0095-4543            Impact factor:   2.907


  14 in total

1.  Evaluating the effectiveness of a comprehensive patient education intervention in a hybrid model of cardiac rehabilitation: A pilot study.

Authors:  Gustavo Arrieta-Bartolomé; Marta Supervia; Alessandra Bertha Castillo Velasquez; Antonia Delgado-Montero; Irene Méndez; Mª Ángeles Ortega Orduñez; Olga Arroyo-Riaño; Crystal Aultman; Paul Oh; Gabriela Lima de Melo Ghisi
Journal:  PEC Innov       Date:  2022-05-30

2.  Assessing Causal Associations of Atopic Dermatitis With Heart Failure and Other Cardiovascular Outcomes: A Mendelian Randomization Study.

Authors:  Heng Chen; Chengui Zhuo; Liangrong Zheng
Journal:  Front Cardiovasc Med       Date:  2022-06-15

3.  Frailty index and risk of cardiovascular diseases: a mendelian randomization study.

Authors:  Jun Li; Heng Chen; Wei He; Limin Luo; Xiaogang Guo
Journal:  Ann Transl Med       Date:  2022-09

4.  Randomized Study Comparing Vildagliptin vs Glibenclamide on Glucose Variability and Endothelial Function in Patients with Type 2 Diabetes Mellitus and Hypertension.

Authors:  Luciana Neves Cosenso-Martin; Lais Yumi Takaoka; Jose Fernando Vilela-Martin
Journal:  Diabetes Metab Syndr Obes       Date:  2020-09-15       Impact factor: 3.168

5.  Association of physical activity, sedentary behaviours and sleep duration with cardiovascular diseases and lipid profiles: a Mendelian randomization analysis.

Authors:  Zhenhuang Zhuang; Meng Gao; Ruotong Yang; Nan Li; Zhonghua Liu; Weihua Cao; Tao Huang
Journal:  Lipids Health Dis       Date:  2020-05-08       Impact factor: 3.876

Review 6.  Forty Years Since the Structural Elucidation of Platelet-Activating Factor (PAF): Historical, Current, and Future Research Perspectives.

Authors:  Ronan Lordan; Alexandros Tsoupras; Ioannis Zabetakis; Constantinos A Demopoulos
Journal:  Molecules       Date:  2019-12-03       Impact factor: 4.411

7.  Combination of R-R Interval and Crest Time in Assessing Complexity Using Multiscale Cross-Approximate Entropy in Normal and Diabetic Subjects.

Authors:  Ming-Xia Xiao; Hai-Cheng Wei; Ya-Jie Xu; Hsien-Tsai Wu; Cheuk-Kwan Sun
Journal:  Entropy (Basel)       Date:  2018-06-27       Impact factor: 2.524

Review 8.  Could Physical Activity Have any Role in Cardiovascular Disease Prevention in Prisoners? A Systematic Review.

Authors:  Veronica Papa; Domenico Tafuri; Mauro Vaccarezza
Journal:  Int J Environ Res Public Health       Date:  2021-02-26       Impact factor: 3.390

9.  Cardiovascular disease risk factors in Spain: A comparison of native and immigrant populations.

Authors:  Elena Rodriguez-Alvarez; Nerea Lanborena; Luisa N Borrell
Journal:  PLoS One       Date:  2020-11-30       Impact factor: 3.240

Review 10.  A review on impedimetric immunosensors for pathogen and biomarker detection.

Authors:  J Leva-Bueno; Sally A Peyman; P A Millner
Journal:  Med Microbiol Immunol       Date:  2020-04-03       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.